Effects of Losartan on Insulin Resistance in Patients With Heart Failure

This study has been completed.

Sponsor:

Information provided by:

Tottori University Hospital

ClinicalTrials.gov Identifier:

NCT00663377

First received: April 18, 2008

Last updated: NA

Last verified: April 2008

History: No changes posted

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	March 2007
Estimated Primary Completion Date:	No date given

No publications provided by Tottori University Hospital

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Ogino K, Kato M, Furuse Y, Kinugasa Y, Kaetsu Y, Mizuta E, Sugihara S, Ishida K, Yanagihara K, Hisatome I, Shigemasa C. Addition of losartan to angiotensin-converting enzyme inhibitors improves insulin resistance in patients with chronic heart failure treated without β-blockers. Circ J. 2010 Nov;74(11):2346-52. Epub 2010 Sep 4.

To Top